Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
30.2M
-
Shares change
-
-29.6K
-
Total reported value, excl. options
-
$197M
-
Value change
-
-$3.72M
-
Put/Call ratio
-
1.86
-
Number of buys
-
44
-
Number of sells
-
-36
-
Price
-
$6.54
Significant Holders of REGULUS THERAPEUTICS INC - COM (RGLS) as of Q3 2015
109 filings reported holding RGLS - REGULUS THERAPEUTICS INC - COM as of Q3 2015.
REGULUS THERAPEUTICS INC - COM (RGLS) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.2M shares
.
Largest 10 shareholders include FMR LLC (7.79M shares), WELLINGTON MANAGEMENT GROUP LLP (4.22M shares), UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (2.21M shares), Capital World Investors (2.02M shares), Foresite Capital Management II, LLC (1.75M shares), BlackRock Fund Advisors (1.48M shares), VANGUARD GROUP INC (1.02M shares), AXA (927K shares), Cormorant Asset Management, LLC (897K shares), and BlackRock Institutional Trust Company, N.A. (681K shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.